New York Codes, Rules and Regulations
Title 15 - Department of Motor Vehicles
Appendices
Appendix 3-A

Current through Register Vol. 44, No. 38, September 21, 2022

(cf. Part 6)

SECTION 3306--PUBLIC HEALTH LAW

SCHEDULES OF CONTROLLED SUBSTANCES

There are hereby established five schedules of controlled substances, to be known as schedules I, II, III, IV and V respectively. Such schedules shall consist of the following substances by whatever name or chemical designation known:

SCHEDULE I

(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:

Acetylmethadol

Allylprodine

Alphacetylmethadol

Alphameprodine

Alphamethadol

Alpha-methylfentanyl (N-(1-(alpha-

methyl-beta-phenyl) ethyl-4-piperidyl))

propionanilide; 1-(1-methyl-2-

phenylethyl)-4-(N-propanilido piperidine)

Benzethidine

Betacetylmethadol

Betameprodine

Betamethadol

Betaprodine

Clonitazene

Dextromoramide

Diampromide

Diethylthiambutene

Difenoxin

Dimenoxadol

Dimepheptanol

Dimethylthiambutene

Dioxaphetyl butyrate

Dipipanone

Ethylmethylthiambutene

Etonitazene

Etoxeridine

Furethidine

Hydroxpethidine

Ketobemidone

Levomoramide

Levophenacylmorphan

Morpheridine

Noracymethadol

Norlevorphanol

Normethadone

Norpipanone

Phenadoxone

Phenampromide

Phenomorphan

Phenoperidine

Piritramide

Proheptazine

Properidine

Propiram

Racemoramide

Tilidine

Trimeperidine

(c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

Acetorphine

Acetyldihydrocodeine

Benylmorphine

Codeine methylbromide

Codeine-N-oxide

Cyprenorphine

Desomorphine

Dihydromorphine

Drotebanol

Etorphine (except hydrochloride salt)

Heroin

Hydromorpinol

Methyldesorphine

Methyldihydromorphine

Morphine methylbromide

Morphine methylsulfonate

Morphine-N-oxide

Myrophine

Nicocodeine

Nicomorphine

Normorphine

Pholcodine

Thebacon

(VIN) ..............................................................................................

(1) 4-bromo-2, 5-dimethoxy-amphetamine. Some trade or other names: 4-bromo-2, 5-dimethoxy-a-methylphenethylamine; 4-bromo-2, 5-DMA

(2) 2, 5-dimethoxyamphetamine. Some trade or other names: 2, 5-dimethoxy-a-methylphenethylamine; 2, 5-DMA

(3) 4-methoxyamphetamine. Some trade or other names: 4-methoxy-a-methylphenethylamine; paramethoxyamphetamine, PMA

(4) 5-methoxy-3; 4-methylenedioxy-amphetamine

(5) 4-methyl-2, 5-dimethoxy-amphetamine. Some trade and other names: 4-methyl-2, 5-dimethoxy-a-methylphenethylamine; "DOM"; and "STP"

(6) 3, 4-methylenedioxy amphetamine

(7) 3, 4, 5-trimethoxy amphetamine

(VIN) ..............................................................................................

(9) Diethyltryptamine. Some trade and other names: N, N-diethyltryptamine; DET

(10) Dimethyltryptamine. Some trade or other names: DMT

(11) Ibogane. Some trade and other names: 7-ethyl-6, 6<<BETA>>, 7,8,9,10,12,13- Octahydro-2-methoxy-6, 9-methano-5h-pyrido (1',2':1,2) azepino (5,4-b) indole: tabermanthe iboga

(12) Lysergic acid diethylamide

(13) Marihuana

(14) Mescaline

(15) Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo(b,d) pyran

(16) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts

(17) N-ethyl-3-piperidyl benzilate

(18) N-methyl-3-piperidyl benzilate

(19) Psilocybin

(20) Psilocyn

(21) Tetrahydrocannabinols. Synthetic equivalents of the substanaces contained in the plant, or in the resinous extractives of cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:

_1 cis or trans tetrahydrocannabinol, and their optical isomers

_6 cis or trans tetrahydrocannabinol, and their optical isomers

_3, 4 cis or trans tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered)

(22) Ethylamine analog of phencyclidine. Some trade or other names: N-ethyl-l-phenycyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE

(VIN) ..............................................................................................

(VIN) ..............................................................................................

(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Mecloqualone

(2) Phencyclidine

(3) Phencyclidine

(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

(1) Fenethylline

(2) N-ethylamphetamine

SCHEDULE II

(a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:

(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, naloxone, and naltrexone, and their respective salts, but including the following:

Raw opium

Opium extracts

Opium fluid extracts

Powdered opium

Granulated opium

Tincture of opium

Codeine

Ethylmorphine

Etorphine hydrochloride

Hydrocodone

Hydromorphone

Metopon

Morphine

Oxycodone

Oxymorphone

Thebaine

(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in this section, except that these substances shall not include the isoquinoline alkaloids of opium.

(3) Opium poppy and poppy straw.

(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, including cocaine and ecgonine, their salts, isomers and salts of isomers, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

(VIN) ..............................................................................................

(c) Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:

(1) Alfentanil

(2) Alphaprodine

(3) Anileridine

(4) Bezitramide

(5) Bulk dextropropoxyphene (non-dosage forms)

(6) Dihydrocodeine

(7) Diphenoxylate

(8) Fentanyl

(9) Isomethadone

(10) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM)

(11) Levomethorphan

(12) Levorphanol

(13) Metazocine

(14) Methadone

(15) Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane

(16) Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenyl propane-carboxylic acid

(17) Pethidine (meperidine)

(18) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

(19) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

(20) Pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

(21) Phenazocine

(22) Piminodine

(23) Racemethorphan

(24) Racemorphan

(25) Sufentanil

(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

(1) Amphetamine, its salts, optical isomers and salts of its optical isomers

(2) Methamphetamine, its salts, isomers, and salts of its isomers

(3) Phenmetrazine and its salts

(4) Methylphenidate

(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Amobarbital

(2) Glutethimide

(3) Pentobarbital

(4) Secobarbital

(f) Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product.

(g) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances:

(1) Immediate precursor to amphetamine and methamphetamine:

(i) Phenylacetone. Some trade or other names: phenyl-2- propanone; P2P; benzyl methyl ketone; methyl benzyl ketone

(VIN) ..............................................................................................

(i) l-phenylcyclohexylamine

(ii) l-piperidinocyclohexanecarbonitrile (PCC)

(h) Anabolic steroids. Unless specifically excepted or unless listed in another schedule, "anabolic steroid" shall mean any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins and corticosteroids) that promotes muscle growth, any drug or hormonal substance that stimulates the endrogenous production of steroids in the human body which acts in the same manner, or any material, compound, mixture, or preparation which contains any amount of the following substances:

Boldenone

Clostebol

Dehydrochlormethyltestosterone

Drostanolone

Ethylestrenol

Fluoxymesterone

Formebulone (formebolone)

Mesterolene

Methandriol

Methandrostenolone

Menthenolone

Methyltestosterone

Mibolerone

Nandrolone

Norethandrolone

Oxandrolone

Oxymesterone

Oxymetholone

Stanolone

Stanozolol

Testosterone

Trenbolone

Any salt, ester or isomer of a drug or substance described or listed in this subdivision, if such salt, ester or isomer promotes muscle growth

(i) Subdivision (h) of this section shall not include any substance containing anabolic steroids expressly intended for administration through implants to cattle or other nonhuman species and that are approved by the Federal Food and Drug Administration solely for such use. Any individual who knowingly and willfully administers to himself or another person, prescribes, dispenses or distributes such substances for other than implantation to cattle or nonhuman species shall be subject to the same penalties as a practitioner who violates the provisions of this section or any other penalties prescribed by law.

(j) Chorionic gonadotrophin. Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any amount of chorionic gonadotrophin.

SCHEDULE III

(a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(VIN) ..............................................................................................

(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under title 21, section 308.32 of the Code of Federal Regulations and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances

(2) Benzphetamine

(3) Chlorphentermine

(4) Clortermine

(5) Phendimetrazine

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

(1) Any compound, mixture or preparation containing:

(i) Amobarbital

(ii) Secobarbital

(iii) Pentobarbital

or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

(2) Any suppository dosage form containing:

(i) Amobarbital

(ii) Secobarbital

(iii) Pentobarbital

or any salt of any of these drugs approved by the Federal Food and Drug Administration for marketing only as a suppository.

(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt therof.

(4) Chlorhexadol

(5) Lysergic acid

(6) Lysergic acid amide

(7) Methyprylon

(8) Sulfondiethylmethane

(9) Sulfonethylmethane

(10) Sulfonmethane

(d) Nalorphine.

(e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.

(2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

SCHEDULE IV

(a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1) Not more than one milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit

(VIN) ..............................................................................................

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenver the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

Alprazolam

Barbital

Bromazepam

Camazepam

Chloral betaine

Chloral hydrate

Chlordiazepoxide

Clobazam

Clonazepam

Clorazepate

Clotiazepam

Cloxazolam

Delorazepam

Diazepam

Estazolam

Etchlorvynol

Ethinamate

Ethyl loflazepate

Fludiazepam

Flunitrazepam

Flurazepam

Halazepam

Haloxazolam

Ketazolam

Loprazolam

Lorazepam

Lormetazepam

Mebutamate

Medazepam

Meprobamate

Methohexital

Methylphenobarbital

(mephobarbital)

Nimetazepam

Nitrazepam

Nordiazepam

Oxazepam

Oxazolam

Paraldehyde

Petrichoral

Phenobarbital

Pinazepam

Prazepam

Temazepam

Tetrazepam

Triazolam

(VIN) ..............................................................................................

(1) Fenfluramine

(e) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers:

(1) Diethylpropion

(2) Mazindol

(3) Pemoline (including organometallic complexes and chelates thereof)

(4) Phentermine

(5) Pipradrol

(VIN) ..............................................................................................

(f) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:

(1) Pentazocine

SCHEDULE V

(a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.

(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.

(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.

(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.

(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.

(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

(c) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation containing any of the following narcotic drugs and their salts, as set forth below:

(1) Buprenorphine

Disclaimer: These regulations may not be the most recent version. New York may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.